Vaniqa, Crème

7680556580022 CH-55658 Crème

Associated product:

VANIQA crème tb 60 g
Vaniqa, Crème
Vaniqa, Crème
Vaniqa, Crème
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
g
Galenic form
Crème
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/02/2022
Patient information leaflet
Français
24/02/2022
Patient information leaflet
Italien
24/02/2022
Summary of Product Characteristics
Allemand
24/02/2022
Summary of Product Characteristics
Français
24/02/2022
Summary of Product Characteristics
Italien
24/02/2022

Detailed composition

Substance Quantity Type Category
(N/A)
115.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
26.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
14.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
0.32 MG Substance HBESI
(N/A)
0.8 MG Substance HBESI

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
55658
Drug name
Vaniqa, Crème
Galenic form
CREM
ATC Code
D11AX16
Authorization status
Z
Dispensing category
B
First authorization
15/04/2003
Authorization expiration date
31/12/9999
IT Number
10.99.0.
Domain
Human medicine
Field of application
Hirsutismus im Gesicht bei Frauen

Package details

Description (FR)
VANIQA crème tb 60 g
Description (DE)
VANIQA Creme Tb 60 g
Market launch
15/04/2003
Narcotic (BTM)
No

Other package sizes (1)

None
30 G
GTIN: None
Not in V1